SMYD3 and breast carcinoma: MCF7 breast cancer cells were used as a control of low MET expression (https://maayanlab.cloud/Harmonizome/gene_set/MCF7/CCLE+Cell+Line+Gene+Mutation+Profiles, accessed on 3 July 2023) [19], while HT29 CRC cells were used as a control of SMYD3 overexpression (Figure 1a) [20,21].